Utilization of mutagenic RAD52/POLθ replication pathways increase for both GOF and p53 null alleles in a transcription independent manner, consistent with mutation signatures that we identify in p53 mutant breast cancers. The gene discussed is TP53; the disease is breast carcinoma.